The role of progestin subdermal implant in the management of adenomyosis: a systematic review

References

• Moawad G, Fruscalzo A, Youssef Y, et al. Adenomyosis: an updated review on diagnosis and classification. J Clin Med. 2023;12(14):4828. doi: 10.3390/jcm12144828.
   PubMed Web of Science ®Google Scholar
• Stratopoulou CA, Donnez J, Dolmans MM. Conservative management of uterine adenomyosis: medical vs. surgical approach. J Clin Med. 2021;10(21):4878. doi: 10.3390/jcm10214878.
   PubMed Web of Science ®Google Scholar
• Capezzuoli T, Rossi M, La Torre F, et al. Hormonal drugs for the treatment of endometriosis. Curr Opin Pharmacol. 2022;67:102311. doi: 10.1016/j.coph.2022.102311.
   PubMedGoogle Scholar
• Ambacher K, Secter M, Sanders AP. The use of progestin subdermal implants in the management of endometriosis-related pain symptoms and quality of life: a systematic review. Curr Med Res Opin. 2022;38(3):479–486. doi: 10.1080/03007995.2022.2031144.
   PubMed Web of Science ®Google Scholar
• Scherer RW, Saldanha IJ. How should systematic reviewers handle conference abstracts? A view from the trenches. Syst Rev. 2019;8(1):264. doi: 10.1186/s13643-019-1188-0.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.
   PubMed Web of Science ®Google Scholar
• Sackett DL, Straus SE, Richardson WS, et al. Evidence-based medicine: how to practice and teach EBM. 2nd ed. Edinburgh: Churchill Livingstone Inc; 2000; p. 173–177.
   Google Scholar
• Murad MH, Sultan S, Haffar S, et al. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60–63. doi: 10.1136/bmjebm-2017-110853.
   PubMedGoogle Scholar
• Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97(8):734–739. doi: 10.1111/j.1471-0528.1990.tb16249.x.
   PubMedGoogle Scholar
• Fraser IS, Critchley HOD, Broder M, et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29(5):383–390. doi: 10.1055/s-0031-1287662.
   PubMed Web of Science ®Google Scholar
• Nie L, Zou H, Ma X, et al. A clinical observational study on the efficacy of subcutaneous etonogestrel implants for adenomyosis in 20 patients. Gynecol Endocrinol. 2021;37(8):735–739. doi: 10.1080/09513590.2021.1922886.
   PubMed Web of Science ®Google Scholar
• Wu J, Huang Y, Chen L, et al. Treatment of adenomyosis with subcutaneous etonogestrel implants: a clinical observational study in 17 patients. Med Sci Monit. 2018;24:6085–6092. doi: 10.12659/MSM.908979.
   PubMed Web of Science ®Google Scholar
• Jones G, Kennedy S, Barnard A, et al. Development of an endometriosis quality-of-life instrument: the endometriosis health profile-30. Obstet Gynecol. 2001;98(2):258–264. doi: 10.1016/s0029-7844(01)01433-8.
   PubMed Web of Science ®Google Scholar
• Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
   PubMed Web of Science ®Google Scholar
• Niu X, Luo Q, Wang C, et al. Effects of etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: results from a prospective, observational study. Medicine (Baltimore). 2021;100(6):e24597.). doi: 10.1097/MD.0000000000024597.
   PubMed Web of Science ®Google Scholar
• Nie LK, Zou HL, Cheng L, et al. Subcutaneous etonogestrel implant combined with endometrial ablation for the treatment of adenomyosis: two case reports. J Obstet Gynaecol Res. 2022;48(1):262–265. doi: 10.1111/jog.15084.
   PubMed Web of Science ®Google Scholar
• Wong S, Naresh A. Etonogestrel subdermal implant-associated regression of endometrial intraepithelial neoplasia. Obstet Gynecol. 2019;133(4):780–782. doi: 10.1097/AOG.0000000000003152.
   PubMed Web of Science ®Google Scholar
• Andguladze A, Tevdorashvili G, Tevdorashvili D, et al. The use of etonogestrel: a modern alternative to the management of the clinical symptoms of adenomyosis. In: 28th Wold Congress on Controversies in Obstetrics, Gynecology & Infertility; 2020; https://www.researchgate.net/publication/344657735_THE_USE_OF_ETONOGESTREL_A_MODERN_ALTERNATIVE_TO_THE_MANAGEMENT_OF_THE_CLINICAL_SYMPTOMS_OF_ADENOMYOSIS?enrichId=rgreqc38f7d47627eb695bc7adaad2fc83da9XXX&enrichSource=Y292ZXJQYWdlOzM0NDY1NzczNTtBUzo5NDY1OTE5ODQ3NzkyNjVAMTYwMjY5NjUyNDg1Mg==&el=1_x_3&_esc=publicationCoverPdf.
   Google Scholar
• Zhang L, Wang X. Influence of etonogestrel implant on improvement of pain relief and life quality in patients with adenomyosis. Chin J Clin Obstet Gynecol. 2023;24(5):487–489.
   Google Scholar
• Stratopoulou CA, Donnez J, Dolmans MM. Origin and pathogenic mechanisms of uterine adenomyosis: what is known so far. Reprod Sci. 2021;28(8):2087–2097. doi: 10.1007/s43032-020-00361-w.
   PubMed Web of Science ®Google Scholar
• Donnez J, Stratopoulo CA, Dolmans MM. Endometriosis and adenomyosis: similarities and differences. Best Pract Res Clin Obstet Gynaecol. 2023;92:102432. doi: 10.1016/j.bpobgyn.2023.102432.
   PubMed Web of Science ®Google Scholar
• Maruyama S, Imanaka S, Nagayasu M, et al. Relationship between adenomyosis and endometriosis; different phenotypes of a single disease. Eur J Obstet Gynecol Reprod Biol. 2020;253:191–197. doi: 10.1016/j.ejogrb.2020.08.019.
   PubMed Web of Science ®Google Scholar
• Carvalho N, Margatho D, Cursino K, et al. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial. Fertil Steril. 2018;110(6):1129–1136. doi: 10.1016/j.fertnstert.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Abbas AM, Samy A, Atwa K, et al. The role of levonorgestrel intra-uterine system in the management of adenomyosis: a systematic review and meta-analysis of prospective studies. Acta Obstet Gynecol Scand. 2020;99(5):571–581. doi: 10.1111/aogs.13798.
   PubMed Web of Science ®Google Scholar
• Mansour D, Korver T, Marintcheva-Petrova M, et al. The effects of implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care. 2008;13:13–28. doi: 10.1080/13625180801959931.
   PubMed Web of Science ®Google Scholar
• Moazzam A, Akin A, Bahamondes L, et al. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant. Hum Reprod. 2016;31(11):2491–2498. doi: 10.1093/humrep/dew222.
   PubMed Web of Science ®Google Scholar
• Grandi G, Barra F, Ferrero S, et al. Hormonal contraception in women with endometriosis: a systematic review. Eur J Contracept Reprod Health Care. 2019;24(1):61–70. doi: 10.1080/13625187.2018.1550576.
   PubMed Web of Science ®Google Scholar
• Sansone A, De Rosa N, Giampaolino P, et al. Effects of etonogestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study. Arch Gynecol Obstet. 2018;298(4):731–736. doi: 10.1007/s00404-018-4851-0.
   PubMed Web of Science ®Google Scholar